Backed by a multi-hundred-million-dollar investment, the expansion underscores Sanofi’s long-term commitment to India’s thriving life sciences ecosystem
Alto met its enrollment goal with 83 patients across 13 US clinical sites
The recommendation is based on new data from continuous safety monitoring of medicines in the EU
Ind-Ra expects chronic therapies to outpace IPM as compliance improves and lifestyle diseases rise
The approval marks a major advance in targeted treatment for this rare, chronic autoimmune disease, offering twice-yearly maintenance dosing after two initial loading doses
Semaglutide is indicated for the treatment of adults with insufficiently controlled type 2 diabetes mellitus
The FDA’s Center for Biologics Evaluation and Research (CBER) cited Moderna’s choice of a licensed standard-dose flu vaccine as the comparator in its Phase 3 trial, saying it “does not reflect the best-available standard of care.”
BioAsia 2026 represents a decisive shift toward execution, scale, and global competitiveness, reflecting the rapid evolution of the life sciences ecosystem
The surge has been driven largely by COCO stores, with 755 COCO and 165 FOFO outlets added this fiscal year
Garijo will be the first woman to lead Sanofi in its history
Subscribe To Our Newsletter & Stay Updated
_256_275.jpeg)
